28 August 2021Braxia (BRAX.C) announces first multi-dose psilocybin trial in CanadaPiers Eaton BRAX.C Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…